Name:
rsob.190136.pdf
Size:
1.935Mb
Format:
PDF
Description:
Full text, Open Access article
Affiliation
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Cancer Research Centre, 555 Wilmslow Road, Manchester M20 4GJ, UKIssue Date
2019
Metadata
Show full item recordAbstract
The oncogenic transcription factor MYC modulates vast arrays of genes, thereby influencing numerous biological pathways including biogenesis, metabolism, proliferation, apoptosis and pluripotency. When deregulated, MYC drives genomic instability via several mechanisms including aberrant proliferation, replication stress and ROS production. Deregulated MYC also promotes chromosome instability, but less is known about how MYC influences mitosis. Here, we show that deregulating MYC modulates multiple aspects of mitotic chromosome segregation. Cells overexpressing MYC have altered spindle morphology, take longer to align their chromosomes at metaphase and enter anaphase sooner. When challenged with a variety of anti-mitotic drugs, cells overexpressing MYC display more anomalies, the net effect of which is increased micronuclei, a hallmark of chromosome instability. Proteomic analysis showed that MYC modulates multiple networks predicted to influence mitosis, with the mitotic kinase PLK1 identified as a central hub. In turn, we show that MYC modulates several PLK1-dependent processes, namely mitotic entry, spindle assembly and SAC satisfaction. These observations thus underpin the pervasive nature of oncogenic MYC and provide a mechanistic rationale for MYC's ability to drive chromosome instability.Citation
Littler S, Sloss O, Geary B, Pierce A, Whetton AD, Taylor SS. Oncogenic MYC amplifies mitotic perturbations. Open Biol. 2019 Aug 30;9(8):190136.Journal
Open BiologyDOI
10.1098/rsob.190136PubMed ID
31455158Additional Links
https://dx.doi.org/10.1098/rsob.190136Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1098/rsob.190136
Scopus Count
Collections
Related articles
- c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instability.
- Authors: Menssen A, Epanchintsev A, Lodygin D, Rezaei N, Jung P, Verdoodt B, Diebold J, Hermeking H
- Issue date: 2007 Feb 1
- Mechanical stress during confined migration causes aberrant mitoses and c-MYC amplification.
- Authors: Bastianello G, Kidiyoor GR, Lowndes C, Li Q, Bonnal R, Godwin J, Iannelli F, Drufuca L, Bason R, Orsenigo F, Parazzoli D, Pavani M, Cancila V, Piccolo S, Scita G, Ciliberto A, Tripodo C, Pagani M, Foiani M
- Issue date: 2024 Jul 16
- Oncogenic KRAS triggers MAPK-dependent errors in mitosis and MYC-dependent sensitivity to anti-mitotic agents.
- Authors: Perera D, Venkitaraman AR
- Issue date: 2016 Jul 14
- Mitotic gene regulation by the N-MYC-WDR5-PDPK1 nexus.
- Authors: Streeter SA, Williams AG, Evans JR, Wang J, Guarnaccia AD, Florian AC, Al-Tobasei R, Liu Q, Tansey WP, Weissmiller AM
- Issue date: 2024 Apr 11
- c-Myc overexpression uncouples DNA replication from mitosis.
- Authors: Li Q, Dang CV
- Issue date: 1999 Aug